Par Drugs And Chemicals Q2 Results FY27: PAT Falls 36.32% to Rs 2.63 Cr, Revenue Rs 27.43 Cr

Par Drugs And Chemicals Ltd (PAR) Q2 Results FY27 announced on 29 October 2026, covering the company's financial performance for the July to September quarter. The results date brought standalone results with revenue of Rs 27.43 Cr and PAT of Rs 2.63 Cr. In this filing, Par Drugs And Chemicals Q2 Results FY27 are compared with the same quarter of last year on a Standalone basis.

This results analysis of Par Drugs And Chemicals Q2 Results walks through the financial highlights, the business drivers disclosed for the company, the FY27 outlook and the risks to watch. Everything below is drawn from the filing figures, so the section that follows sets out the numbers side by side.

Click Here – Get Free Investment Predictions

Par Drugs And Chemicals Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 27.43 Cr	Rs 28.66 Cr	-4.29% YoY
Operating Profit	Rs 4.5 Cr	Rs 6.07 Cr	-25.86% YoY
Net Profit (PAT)	Rs 2.63 Cr	Rs 4.13 Cr	-36.32% YoY

Source: company filing for Par Drugs And Chemicals Q2 Results FY27, 29 October 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Par Drugs And Chemicals Q2 Results: What Stands Out

• Revenue of Rs 27.43 Cr was lower than the Rs 28.66 Cr reported in the same quarter last year, a decline of 4.29%.
• PAT of Rs 2.63 Cr compares with Rs 4.13 Cr a year ago, so net profit fell 36.32% on a YoY basis.
• Operating Profit of Rs 4.5 Cr was down 25.86% from Rs 6.07 Cr, a smaller drop than the fall in PAT.
• Profit fell faster than sales in Par Drugs And Chemicals Q2 Results FY27, and the YoY growth readings are negative for all three lines.
• The next section places these movements in context in the performance analysis of the quarterly results.

Par Drugs And Chemicals Q2 Results FY27: Performance Analysis

The numbers show a quarter in which revenue, Operating Profit and PAT were all lower than a year earlier. Revenue slipped 4.29% to Rs 27.43 Cr, Operating Profit fell 25.86% to Rs 4.5 Cr and PAT dropped 36.32% to Rs 2.63 Cr, all on a Standalone basis.

The pattern is clear in the arithmetic. A revenue decline of Rs 1.23 Cr was accompanied by a fall of Rs 1.57 Cr in Operating Profit and Rs 1.5 Cr in PAT. In Par Drugs And Chemicals Q2 Results FY27, the profit lines therefore moved by more than revenue did in percentage terms.

The Univest Screener lets readers track how Par Drugs And Chemicals Q2 Results compare across later disclosures. For this quarter, the supplied data confirms the results but does not establish the specific cause of the decline, so the results analysis turns to the quarterly results drivers disclosed for the company.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Return on Capital Employed – The quarterly results of Par Drugs And Chemicals sit alongside a return on capital employed of 16.52% in FY26. This is a full-year measure of how efficiently the company used the capital invested in the business, and it frames the latest quarter in a longer context.

Almost Debt Free – The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26. A balance sheet with virtually no borrowings means interest costs are not a large factor in how the quarterly profit line moves.

Net Profit Margin – Net profit margin narrowed to 9.6% from 14.4% in the comparison quarter. This margin is calculated on the revenue of Rs 27.43 Cr and shows how much of each rupee of sales reached PAT in the latest quarter.

FY27 Outlook After Par Drugs And Chemicals Q2 Results

The FY27 outlook depends on the quarters still to be reported. Par Drugs And Chemicals Q2 Results FY27, declared on the results date of 29 October 2026, give the second-quarter reading of the year, and full-year results will be built from this quarter with the ones before and after it.

Readers following this results analysis can watch whether net profit stays near Rs 2.63 Cr or moves back toward the Rs 4.13 Cr of the comparison quarter. The Univest app carries the company's updated filings, and the risks below set out what to monitor.

Key Risks to Watch After Par Drugs And Chemicals Q2 Results FY27

Net Profit Decline

Net profit fell 36.3% year on year to Rs 2.63 Cr. Investors can watch whether later filings after Par Drugs And Chemicals Q2 Results FY27 show the same YoY growth direction or a different one.

Volatile Quarterly Earnings

Quarterly net profit has been volatile, ranging from Rs 0.85 Cr to Rs 4.80 Cr over the last 5 quarters. A wide range makes any single quarter a limited guide to the next one.

Lower Revenue

Revenue declined 4.3% year on year to Rs 27.43 Cr in the latest quarter. Sales are the base on which every profit line is built, so the revenue trend remains a number to follow.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Par Drugs And Chemicals Q2 Results FY27 show a Standalone quarter with revenue of Rs 27.43 Cr, Operating Profit of Rs 4.5 Cr and PAT of Rs 2.63 Cr, all lower YoY. These quarterly results and the standalone results context are best read with later filings, and the reading of Par Drugs And Chemicals Q2 Results should be checked with a SEBI-registered advisor before acting.

Frequently Asked Questions on Par Drugs And Chemicals Q2 Results FY27

What are Par Drugs And Chemicals Q2 Results FY27?

Ans. Par Drugs And Chemicals Q2 Results FY27 are the standalone results for July to September 2026, with revenue of Rs 27.43 Cr and PAT of Rs 2.63 Cr. Alongside this, the results analysis in the Financial Highlights covers each line.

What is the results date for Par Drugs And Chemicals Q2 Results FY27?

Ans. The results date for Par Drugs And Chemicals Q2 Results FY27 is 29 October 2026, covering the July to September 2026 quarter. The Quick Answer box at the top of the article carries this results date with the key figures.

What revenue was reported in Par Drugs And Chemicals Q2 Results FY27?

Ans. Par Drugs And Chemicals reported revenue of Rs 27.43 Cr in the quarter, compared with Rs 28.66 Cr a year earlier. Alongside this, the Financial Highlights table sets out the same revenue figures on a Standalone basis.

What net profit was reported in Par Drugs And Chemicals Q2 Results FY27?

Ans. Par Drugs And Chemicals reported net profit of Rs 2.63 Cr for the quarter, against Rs 4.13 Cr in the same quarter last year, which means a 36.32% decline as covered in Key Takeaways.

How much YoY growth did revenue show in Par Drugs And Chemicals Q2 Results FY27?

Ans. Revenue showed YoY growth of minus 4.29%, falling from Rs 28.66 Cr to Rs 27.43 Cr. Compared with this, Operating Profit fell 25.86%, a movement explained in the Performance Analysis section.

Did net profit rise or fall in Par Drugs And Chemicals Q2 Results?

Ans. Par Drugs And Chemicals Q2 Results show that net profit fell, from Rs 4.13 Cr to Rs 2.63 Cr, a 36.32% decline. This means PAT dropped by Rs 1.5 Cr, which the Performance Analysis section sets against revenue.

What was the Operating Profit in Par Drugs And Chemicals Q2 Results FY27?

Ans. Operating Profit in Par Drugs And Chemicals Q2 Results FY27 was Rs 4.5 Cr, compared with Rs 6.07 Cr a year earlier. This is a 25.86% decline, while the Key Takeaways section lists it beside revenue and PAT.

Are Par Drugs And Chemicals Q2 Results consolidated results or standalone results?

Ans. Par Drugs And Chemicals Q2 Results are standalone results, reported on a Standalone basis for the company alone. So every revenue, Operating Profit and PAT figure in this article follows that basis, as the Quick Answer states.

What business factors shaped Par Drugs And Chemicals Q2 Results FY27?

Ans. The factors for Par Drugs And Chemicals are a return on capital employed of 16.52% in FY26 and an almost debt free balance sheet. Alongside these, net profit margin narrowed to 9.6% from 14.4%, per the Key Business Factors section.

What are the key risks after Par Drugs And Chemicals Q2 Results FY27?

Ans. The risks include a 36.3% year on year fall in net profit, volatile quarterly earnings between Rs 0.85 Cr and Rs 4.80 Cr and lower revenue, so the results analysis points to the Key Risks section.

What is the outlook after Par Drugs And Chemicals Q2 Results?

Ans. The FY27 outlook depends on the quarters still to be declared, as full-year results will be built from each filing. Compared with this single reading, the Outlook section suggests watching how net profit moves from Rs 2.63 Cr.

Where can I find the complete Par Drugs And Chemicals Q2 Results FY27 data?

Ans. The complete Par Drugs And Chemicals Q2 Results FY27 data is in the Financial Highlights table of this article, which lists revenue, Operating Profit and PAT with YoY changes. Alongside this, the Univest Screener tracks the company's later filings.